3月5日A股投資避雷針︱江南奕帆:股東陳淵技和龔建芬擬合計減持不超過3%股份;華榮股份:相關機器人產品在安工智能業務中的應用仍處於起步階段
文科股份股東澤廣投資擬減持不超過1.6%股份;邁信林股東伊犁蘇新及道豐投資擬減持290.85萬股;江南奕帆股東陳淵技和龔建芬擬合計減持不超過3%股份;天正電氣公司產品實際銷售於機器人行業的營業收入不到200萬元;海立股份表示海立特冷有銷售光刻機用冷卻系統,該業務規模較小;華榮股份表示相關機器人產品在安工智能業務中的應用仍處於起步階段

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.